Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Molecular Understanding of HIV-1 Latency.

Abbas W, Herbein G.

Adv Virol. 2012;2012:574967. doi: 10.1155/2012/574967. Epub 2012 Apr 4.

2.

HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes.

Redel L, Le Douce V, Cherrier T, Marban C, Janossy A, Aunis D, Van Lint C, Rohr O, Schwartz C.

J Leukoc Biol. 2010 Apr;87(4):575-88. doi: 10.1189/jlb.0409264. Epub 2009 Oct 2. Review.

3.

Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage.

Le Douce V, Herbein G, Rohr O, Schwartz C.

Retrovirology. 2010 Apr 9;7:32. doi: 10.1186/1742-4690-7-32. Review.

4.
5.

Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.

Colin L, Van Lint C.

Retrovirology. 2009 Dec 4;6:111. doi: 10.1186/1742-4690-6-111. Review.

6.

The gut mucosal viral reservoir in HIV-infected patients is not the major source of rebound plasma viremia following interruption of highly active antiretroviral therapy.

Lerner P, Guadalupe M, Donovan R, Hung J, Flamm J, Prindiville T, Sankaran-Walters S, Syvanen M, Wong JK, George MD, Dandekar S.

J Virol. 2011 May;85(10):4772-82. doi: 10.1128/JVI.02409-10. Epub 2011 Feb 23.

7.

HIV-1 latency in monocytes/macrophages.

Kumar A, Abbas W, Herbein G.

Viruses. 2014 Apr 22;6(4):1837-60. doi: 10.3390/v6041837. Review.

8.

Hide-and-seek: the challenge of viral persistence in HIV-1 infection.

Geeraert L, Kraus G, Pomerantz RJ.

Annu Rev Med. 2008;59:487-501. Review.

PMID:
17845138
9.

Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs.

Coiras M, López-Huertas MR, Pérez-Olmeda M, Alcamí J.

Nat Rev Microbiol. 2009 Nov;7(11):798-812. doi: 10.1038/nrmicro2223. Review.

PMID:
19834480
10.

Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.

Chun TW, Engel D, Berrey MM, Shea T, Corey L, Fauci AS.

Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8869-73.

11.

Hematopoietic stem/precursor cells as HIV reservoirs.

McNamara LA, Collins KL.

Curr Opin HIV AIDS. 2011 Jan;6(1):43-8. doi: 10.1097/COH.0b013e32834086b3. Review.

12.

Antiretroviral compounds: mechanisms underlying failure of HAART to eradicate HIV-1.

Shehu-Xhilaga M, Tachedjian G, Crowe SM, Kedzierska K.

Curr Med Chem. 2005;12(15):1705-19. Review.

PMID:
16029143
13.
14.

A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy.

Dinoso JB, Rabi SA, Blankson JN, Gama L, Mankowski JL, Siliciano RF, Zink MC, Clements JE.

J Virol. 2009 Sep;83(18):9247-57. doi: 10.1128/JVI.00840-09. Epub 2009 Jul 1.

15.
16.

Reservoirs of HIV replication after successful combined antiretroviral treatment.

Belmonte L, Baré P, de Bracco MM, Ruibal-Ares BH.

Curr Med Chem. 2003 Feb;10(4):303-12. Review.

PMID:
12570703
17.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
18.

HIV reservoirs, latency, and reactivation: prospects for eradication.

Dahl V, Josefsson L, Palmer S.

Antiviral Res. 2010 Jan;85(1):286-94. doi: 10.1016/j.antiviral.2009.09.016. Epub 2009 Oct 4. Review.

PMID:
19808057
19.

[Molecular basis of HIV-1 latency - part I: physiology of HIV-1 latency].

Schwartz C, Le Douce V, Cherrier T, Redel L, Marban C, Aunis D, Rohr O.

Med Sci (Paris). 2010 Feb;26(2):159-63. doi: 10.1051/medsci/2010262159. Review. French.

20.

A reservoir for HIV in patients on combination antiretroviral therapy.

Siliciano RF.

Hopkins HIV Rep. 1998 Jan;10(1):1, 5-6, 11.

PMID:
11365130

Supplemental Content

Support Center